2021
DOI: 10.1002/ana.26233
|View full text |Cite
|
Sign up to set email alerts
|

Tau‐Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease

Abstract: Tau neurofibrillary tangles (T) are the primary driver of downstream neurodegeneration (N) and subsequent cognitive impairment in Alzheimer's disease (AD). However, there is substantial variability in the T-N relationshipmanifested in higher or lower atrophy than expected for level of tau in a given brain region. The goal of this study was to determine if region-based quantitation of this variability allows for identification of underlying modulatory factors, including polypathology. Methods: Cortical thicknes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
28
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1
1

Relationship

4
5

Authors

Journals

citations
Cited by 23 publications
(31 citation statements)
references
References 45 publications
(75 reference statements)
3
28
0
Order By: Relevance
“…Since N S and N M are linked, it is reasonable to predict that T/N S and T/N M relationships are also associated. Indeed, clustering with T/N S approaches yields groups with relative resilience or vulnerability to T 25 . The median regional correlation coefficient between T/N S and T/N M residuals was 0.29, suggesting that while T/N S and T/N M relationships are similar, they may provide some unique information.…”
Section: Discussionmentioning
confidence: 99%
“…Since N S and N M are linked, it is reasonable to predict that T/N S and T/N M relationships are also associated. Indeed, clustering with T/N S approaches yields groups with relative resilience or vulnerability to T 25 . The median regional correlation coefficient between T/N S and T/N M residuals was 0.29, suggesting that while T/N S and T/N M relationships are similar, they may provide some unique information.…”
Section: Discussionmentioning
confidence: 99%
“…β-amyloid deposition and tauopathy, as assessed by levels of Aβ species and p-Tau (p-Tau 181, 217, 231), respectively, in cerebrospinal fluid (CSF) and plasma as well as directly by positron emission tomography (PET), can be used to detect Aβ- and Tau-related neuropathology prior to the onset of cognitive impairment [ 7 ]. Recent studies have demonstrated that post-translational alterations of Tau also play a role in the rate of clinical AD progression [ 8 ] and variability in tauopathies across brain regions of patients [ 9 ]. Collectively, these studies suggest that AD is a heterogeneous neurodegenerative condition with respect to both clinical presentation and progression of AD pathology.…”
Section: Introductionmentioning
confidence: 99%
“…Age itself is associated with structural changes to regional thickness and volume of grey matter which is at least partially dissociable from structural changes associated with typical AD 31,36 . As such, we previously predicted and found that age was associated with a more global measure of T-N mismatch 21 . In the current analysis, vulnerable groups do tend to be older than resilient ones, with the canonical group around the mean age of the overall cohort.…”
Section: Discussionmentioning
confidence: 77%
“…There were 184 amyloid positive (A+) and 159 amyloid negative (A-) patients included in this study. Most of the A+ patients were also in our prior study 21 . The summarized clinical characteristics of the cohort are reported in Table S4.…”
Section: Adni Datasetmentioning
confidence: 90%